Search

EU Regulators Approve Akcea's Inotersen. FDA Decisions Are Next

EU REGULATORS APPROVE AKCEA'S INOTERSEN. FDA DECISIONS ARE NEXT

Akcea Therapeutics has beaten rival Alnylam Pharmaceuticals to a first drug approval, getting the nod for its drug inotersen in the...

BioCryst Drops Idera Pharma Merger After Shareholders Veto Deal

BIOCRYST DROPS IDERA PHARMA MERGER AFTER SHAREHOLDERS VETO DEAL

BioCryst Pharmaceuticals is ending a plan to merge with Idera Pharmaceuticals and form a single company focused on rare diseases. Durham,...

 
 
 

SYNTIMMUNE PICKS UP VERTEX VP FOR CMO AS LEADERSHIP CHANGES CONTINUE

Syntimmune has brought on Vertex Pharmaceuticals' Mario Saltarelli as its new chief medical officer. The move follows several leadership...

ANALYST - INSIGHT ECONOMICS, LLC - LA JOLLA, CA

Biotechnology, Consumer Electronics, E-Commerce, Entertainment, Financial Services, Medical Device, Pharmaceutical, Security and Defense,...

 
 
 

THERMO FISHER SCIENTIFIC TO PROVIDE ANTIBODY PUBLICATION DATA ON ITS WEBSITE

Researchers can view published data on antibodies directly on the website to help better understand antibody performance CARLSBAD,...

BIOVIA - SR. SOFTWARE ENGINEER - DASSAULT SYSTÈMES - SAN DIEGO, CA

Our customer base includes the world's largest pharmaceutical, biotechnology, chemical and petroleum companies. Imagine new horizons:...From...

 
 
 

IONIS-BACKED DYNACURE BAGS €47M TO START CLINICAL TRIALS

Dynacure has raised €47 million to take an antisense oligonucleotide therapy into the clinic. The French biotech picked up the centronuclear...

 
 
 

NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES RESULTS FROM PIVOTAL STUDY OF TEGSEDI FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS

TEGSEDI treatment demonstrated substantial improvement in measures of neuropathy progression and quality of life-Akcea prepared for...

Priority Changes for Novartis Spell the End for Aveo Pharma Alliance

PRIORITY CHANGES FOR NOVARTIS SPELL THE END FOR AVEO PHARMA ALLIANCE

When Aveo Pharmaceuticals found itself floundering three years ago in the wake of the FDA's rejection of its lead cancer drug, Novartis...

 
 
 
Lundbeck Reaches Across Atlantic, Picks Dunshire for CEO Post

LUNDBECK REACHES ACROSS ATLANTIC, PICKS DUNSHIRE FOR CEO POST

Deborah Dunsire, a veteran of Boston's biotech scene, is taking off. Specifically, she's taking the top job at Danish pharma firm Lundbeck,...

The Art of Perseverance: Meet Xconomy's Six CEO Award Finalists

THE ART OF PERSEVERANCE: MEET XCONOMY'S SIX CEO AWARD FINALISTS

The Xconomy Awards are back, and today we're kicking things off by taking a look at our first set of finalists -the top Boston biotech...

 
 
 
Amazon beat out Walmart in a deal for a small pharmacy startup - and it shows just how intense the rivalry's gotten

AMAZON BEAT OUT WALMART IN A DEAL FOR A SMALL PHARMACY STARTUP - AND IT SHOWS JUST HOW INTENSE THE RIVALRY'S GOTTEN

Amazon just signaled its intent to get into the pharmaceutical business through the acquisition of a startup called PillPack . The...

IAmScience David Porciani

IAMSCIENCE DAVID PORCIANI

By Erica Overfelt | Bond LSC David Porciani was inspired into a science career. Growing up along the Mediterranean Sea in Livorno,...

 
 
 
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On

BIO ROUNDUP: BIG BUCKS FOR CALICO, DATA DUMPS & THE IPO WAVE ROLLS ON

If you're running a privately held biotech, the time to go public is now. Clinical data already in hand or not, biotechs have charged...

 
 
 
Amazon acquires PillPack, an online pharmacy that delivers medicine to your door

AMAZON ACQUIRES PILLPACK, AN ONLINE PHARMACY THAT DELIVERS MEDICINE TO YOUR DOOR

Amazon has announced plans to acquire PillPack, an online pharmacy that sorts patients' medications into personalized packets based...

Akebia Merges With Keryx As Anemia Drug Race Nears Finish Line

AKEBIA MERGES WITH KERYX AS ANEMIA DRUG RACE NEARS FINISH LINE

The race to treat anemia with a pill, not an injectable biologic, just took a new turn. Akebia Therapeutics , which is battling with...

 
 
 
The CEO behind the first prescription marijuana drug explains what the move means for the future of cannabis-based medicine

THE CEO BEHIND THE FIRST PRESCRIPTION MARIJUANA DRUG EXPLAINS WHAT THE MOVE MEANS FOR THE FUTURE OF CANNABIS-BASED MEDICINE

Monday was both a milestone and a jumping off point for the CEO of GW Pharmaceuticals, whose medicine just became the first marijuana-derived...